Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Froehner

Showing results (141-150 of 191) with videos related to

Pageof 20
Sort By:
Urologia Internationalis|February 1, 2013
Systematic assessment of complications and outcome of radical cystectomy undertaken with curative intent in patients with comorbidity and over 75 years of ageVladimir Novotny, Oliver W Hakenberg, Michael Froehner, et al.
International Journal of Oncology|May 13, 2004
Quantification of disseminated tumor cells in the bloodstream of patients with hormone-refractory prostate carcinoma undergoing cytotoxic chemotherapyUta Schmidt, Udo Bilkenroth, Clemens Linné, et al.
World Journal of Urology|December 15, 2015
Age, American Society of Anesthesiologists physical status classification and Charlson score are independent predictors of 90-day mortality after radical cystectomyVladimir Novotny, Michael Froehner, Rainer Koch, et al.
European Urology Open Science|August 2, 2021
Decreasing Non-bladder-cancer Mortality After Radical CystectomyMichael Froehner, Rainer Koch, Ulrike Heberling, et al.
Urology|August 30, 2008
Detailed analysis of Charlson comorbidity score as predictor of mortality after radical prostatectomyMichael Froehner, Rainer Koch, Rainer J Litz, et al.
BMC Cancer|February 13, 2014
Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAsKati Erdmann, Knut Kaulke, Cathleen Thomae, et al.
World Journal of Urology|July 4, 2019
Which comorbidity classification is best suited to identify patients at risk for 90-day and long-term non-bladder cancer mortality after radical cystectomy?Michael Froehner, Rainer Koch, Ulrike Heberling, et al.
Urologia Internationalis|June 17, 2020
Validation of a Questionnaire-Suitable Comorbidity Index in Patients Undergoing Radical CystectomyMichael Froehner, Rainer Koch, Ulrike Heberling, et al.
Urologia Internationalis|September 3, 2018
Gender and Mortality after Radical Cystectomy: Competing Risk AnalysisUlrike Heberling, Rainer Koch, Matthias Hübler, et al.
Urology|October 16, 2010
Importance of erythrocyte band III anion transporter (SLC4A1) on oxalate clearance of calcium oxalate monohydrate stone-formering patients vs. normal controlsSven Oehlschläger, Susanne Fuessel, Axel Meye, et al.
Pageof 20

Showing results (141-150 of 191) with videos related to

Sort By:
Pageof 20
Urologia Internationalis|February 1, 2013
Systematic assessment of complications and outcome of radical cystectomy undertaken with curative intent in patients with comorbidity and over 75 years of ageVladimir Novotny, Oliver W Hakenberg, Michael Froehner, et al.
International Journal of Oncology|May 13, 2004
Quantification of disseminated tumor cells in the bloodstream of patients with hormone-refractory prostate carcinoma undergoing cytotoxic chemotherapyUta Schmidt, Udo Bilkenroth, Clemens Linné, et al.
World Journal of Urology|December 15, 2015
Age, American Society of Anesthesiologists physical status classification and Charlson score are independent predictors of 90-day mortality after radical cystectomyVladimir Novotny, Michael Froehner, Rainer Koch, et al.
European Urology Open Science|August 2, 2021
Decreasing Non-bladder-cancer Mortality After Radical CystectomyMichael Froehner, Rainer Koch, Ulrike Heberling, et al.
Urology|August 30, 2008
Detailed analysis of Charlson comorbidity score as predictor of mortality after radical prostatectomyMichael Froehner, Rainer Koch, Rainer J Litz, et al.
BMC Cancer|February 13, 2014
Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAsKati Erdmann, Knut Kaulke, Cathleen Thomae, et al.
World Journal of Urology|July 4, 2019
Which comorbidity classification is best suited to identify patients at risk for 90-day and long-term non-bladder cancer mortality after radical cystectomy?Michael Froehner, Rainer Koch, Ulrike Heberling, et al.
Urologia Internationalis|June 17, 2020
Validation of a Questionnaire-Suitable Comorbidity Index in Patients Undergoing Radical CystectomyMichael Froehner, Rainer Koch, Ulrike Heberling, et al.
Urologia Internationalis|September 3, 2018
Gender and Mortality after Radical Cystectomy: Competing Risk AnalysisUlrike Heberling, Rainer Koch, Matthias Hübler, et al.
Urology|October 16, 2010
Importance of erythrocyte band III anion transporter (SLC4A1) on oxalate clearance of calcium oxalate monohydrate stone-formering patients vs. normal controlsSven Oehlschläger, Susanne Fuessel, Axel Meye, et al.
Pageof 20